Evidence map›Paper›PMID 32792869›Full record

ReviewPostepy dermatologii i alergologii2020

Ocular manifestations of dermal paraneoplastic syndromes.

Alexander Zdebik, Hanka Lantzsch, Norbert Buhles, Natalia Zdebik

Open access · goldAbstract readReview
In one paragraph

Review in Postepy dermatologii i alergologii, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alexander ZdebikDepartment and Clinic of Dermatology, Asklepios Nordseeklinik, Sylt/Westerland, Germany.
Hanka LantzschDepartment and Clinic of Dermatology, Asklepios Nordseeklinik, Sylt/Westerland, Germany.
Norbert BuhlesDepartment and Clinic of Dermatology, Asklepios Nordseeklinik, Sylt/Westerland, Germany.
Natalia ZdebikDepartment and Clinic of Ophthalmology, Wroclaw Medical University, Wroclaw, Poland.
Asklepios Kliniken Hamburg · DEWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermal paraneoplastic syndromes are non-malignant disorders, caused indirectly by the increase in growth factors or as immunological reactions, which lead to a variety of inflammatory, hyperkeratotic or proliferative skin reactions. They can occur as facultative or obligate paraneoplastic dermatoses, which are associated with oncological processes (solid tumours or hematologic diseases). The recognition of paraneoplastic skin disorders can accelerate proper diagnosis and determine better prognosis for the patient and is also important to clinicians because it is often the first symptom of life-threatening malignancies. Many of them may also cause ocular changes that can lead to serious complications including perforation of the eye bulb, vascular changes in the retina resulting in vision loss and demand multidisciplinary co-operation with an ophthalmologist. This manuscript is a review of the literature about eye disorders in association with dermal paraneoplastic syndromes.

Indexed as

acanthosis nigricansocular manifestationsparaneoplastic pemphigusparaneoplastic syndromespsoriasisskinSweet syndrome

Identifiers

PMID32792869
PMCPMC7394149
OpenAlexW3043824093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.